MicroRNAs and Their Role for T Stage Determination and Lymph Node Metastasis in Early Colon Carcinoma

Overview

Journal Clin Exp Metastasis

Specialty Oncology

Date 2017 Nov 15

PMID 29134398

Citations 10

Authors

Melanie Rammer

Gerald Webersinke

Sophie Haitchi-Petnehazy

Eva Maier

Hubert Hackl

Pornpimol Charoentong

Theodora Malli

Maria Steinmair

Andreas L Petzer

Holger Rumpold

Affiliations

Soon will be listed here.

Abstract

Worldwide, colon cancer is among the most common cancer entities. Understanding the molecular background is the key to enable accurate stage determination, which is crucial to assess optimal therapy options. The search for preoperative biomarkers is ongoing. In recent years, several studies have proposed a diagnostic and prognostic role for miRNAs in cancer. Aim of this study was to evaluate miRNA expression patterns correlating with tumor stage, especially lymph node metastasis, in primary colon carcinoma tissue. Screening was accomplished using GeneChip miRNA v3.0 arrays (Thermo Fisher Scientific, Waltham, MA, USA) and validated via TaqMan qPCR assays (Thermo Fisher Scientific, Waltham, MA, USA) to investigate miRNA expressions in 168 FFPE and 83 fresh frozen colon carcinoma samples. Regarding lymph node status, analyses displayed no significantly differential miRNA expression. Interestingly, divergent expression of miR-18a-5p, miR-20a-5p, miR-21-5p, miR-152-3p and miR-1973 was detected in stage pT1. Although miRNAs might not represent reliable biomarkers regarding lymph node metastasis status, they could support risk assessment in stage T1 tumors.

Citing Articles

MicroRNA Expression Signatures in Clear Cell Renal Cell Carcinoma: High-Throughput Searching for Key miRNA Markers in Patients from the Volga-Ural Region of Eurasian Continent.

Gilyazova I, Ivanova E, Izmailov A, Sharifgaliev I, Karunas A, Pudova E Int J Mol Sci. 2023; 24(8).

PMID: 37108073 PMC: 10139074. DOI: 10.3390/ijms24086909.

Overexpressed lncRNA LINC00893 Suppresses Progression of Colon Cancer by Binding with miR-146b-3p to Upregulate PRSS8.

Zhu J, Jiang C, Hui H, Sun Y, Tao M, Liu Y J Oncol. 2022; 2022:8002318.

PMID: 35571488 PMC: 9098335. DOI: 10.1155/2022/8002318.

Circulating plasma exosomal miRNA profiles serve as potential metastasis-related biomarkers for hepatocellular carcinoma.

Huang C, Tang S, Shen D, Li X, Liang L, Ding Y Oncol Lett. 2021; 21(2):168.

PMID: 33552286 PMC: 7798106. DOI: 10.3892/ol.2021.12429.

miR-152-3p Affects the Progression of Colon Cancer via the KLF4/IFITM3 Axis.

Zhu X, Shen Z, Man D, Ruan H, Huang S Comput Math Methods Med. 2020; 2020:8209504.

PMID: 32952601 PMC: 7481932. DOI: 10.1155/2020/8209504.

cfRNAs as biomarkers in oncology - still experimental or applied tool for personalized medicine already?.

Kolenda T, Guglas K, Baranowski D, Sobocinska J, Kopczynska M, Teresiak A Rep Pract Oncol Radiother. 2020; 25(5):783-792.

PMID: 32904167 PMC: 7451588. DOI: 10.1016/j.rpor.2020.07.007.

References

Lee Y, Lee Y, Chuang J, Lee J . Differences in survival between colon and rectal cancer from SEER data. PLoS One. 2013; 8(11):e78709. PMC: 3827090. DOI: 10.1371/journal.pone.0078709. View

Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C . Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012; 30(16):1926-33. DOI: 10.1200/JCO.2011.40.1836. View

Kritsanasakul A, Boonpipattanapong T, Wanitsuwan W, Phukaoloun M, Prechawittayakul P, Sangkhathat S . Impact of lymph node retrieval on surgical outcomes in colorectal cancers. J Surg Oncol. 2012; 106(3):238-42. DOI: 10.1002/jso.22156. View

Kawada K, Taketo M . Significance and mechanism of lymph node metastasis in cancer progression. Cancer Res. 2011; 71(4):1214-8. DOI: 10.1158/0008-5472.CAN-10-3277. View

Li L, Plummer S, Thompson C, Tucker T, Casey G . Association between phosphatidylinositol 3-kinase regulatory subunit p85alpha Met326Ile genetic polymorphism and colon cancer risk. Clin Cancer Res. 2008; 14(3):633-7. DOI: 10.1158/1078-0432.CCR-07-1211. View

Humphreys K, McKinnon R, Michael M . miR-18a inhibits CDC42 and plays a tumour suppressor role in colorectal cancer cells. PLoS One. 2014; 9(11):e112288. PMC: 4224453. DOI: 10.1371/journal.pone.0112288. View

Zhao G, Guo Y, Chen Z, Wang Y, Yang C, Dudas A . miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian Cancer. J Cancer Sci Ther. 2016; 7(2):34-43. PMC: 4725318. DOI: 10.4172/1948-5956.1000322. View

Schetter A, Leung S, Sohn J, Zanetti K, Bowman E, Yanaihara N . MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008; 299(4):425-36. PMC: 2614237. DOI: 10.1001/jama.299.4.425. View

Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing C . Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg. 2010; 14(7):1170-9. DOI: 10.1007/s11605-010-1202-2. View

10.

Della Vittoria Scarpati G, Calura E, Di Marino M, Romualdi C, Beltrame L, Malapelle U . Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients. Biomed Res Int. 2014; 2014:840921. PMC: 4128171. DOI: 10.1155/2014/840921. View

11.

Li J, Chen Y, Zhao J, Kong F, Zhang Y . miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer Lett. 2011; 304(1):52-9. DOI: 10.1016/j.canlet.2011.02.003. View

12.

Li H, Dai S, Zhen T, Shi H, Zhang F, Yang Y . Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer. Eur J Cancer. 2014; 50(6):1207-21. DOI: 10.1016/j.ejca.2013.12.010. View

13.

Wang X, Wang J, Ma H, Zhang J, Zhou X . Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Med Oncol. 2011; 29(2):919-27. DOI: 10.1007/s12032-011-9880-5. View

14.

Schee K, Boye K, Abrahamsen T, Fodstad O, Flatmark K . Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer. BMC Cancer. 2012; 12:505. PMC: 3519622. DOI: 10.1186/1471-2407-12-505. View

15.

Kulda V, Pesta M, Topolcan O, Liska V, Treska V, Sutnar A . Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet Cytogenet. 2010; 200(2):154-60. DOI: 10.1016/j.cancergencyto.2010.04.015. View

16.

Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M . Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology. 2008; 72(5-6):397-402. DOI: 10.1159/000113489. View

17.

Xiong B, Cheng Y, Ma L, Zhang C . MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells. Int J Oncol. 2012; 42(1):219-28. DOI: 10.3892/ijo.2012.1707. View

18.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

19.

Chee C, Meropol N . Current status of gene expression profiling to assist decision making in stage II colon cancer. Oncologist. 2014; 19(7):704-11. PMC: 4077445. DOI: 10.1634/theoncologist.2013-0471. View

20.

Cserni G . Nodal staging of colorectal carcinomas and sentinel nodes. J Clin Pathol. 2003; 56(5):327-35. PMC: 1769958. DOI: 10.1136/jcp.56.5.327. View